Mayflower Financial Advisors LLC Has $259,000 Stake in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Mayflower Financial Advisors LLC cut its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 40.0% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 496 shares of the medical equipment provider’s stock after selling 330 shares during the quarter. Mayflower Financial Advisors LLC’s holdings in Intuitive Surgical were worth $259,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors also recently modified their holdings of ISRG. Massachusetts Financial Services Co. MA bought a new position in Intuitive Surgical during the 3rd quarter valued at $558,807,000. International Assets Investment Management LLC lifted its position in shares of Intuitive Surgical by 49,383.6% during the third quarter. International Assets Investment Management LLC now owns 1,090,619 shares of the medical equipment provider’s stock valued at $535,788,000 after purchasing an additional 1,088,415 shares in the last quarter. FMR LLC boosted its holdings in Intuitive Surgical by 8.3% during the third quarter. FMR LLC now owns 10,971,085 shares of the medical equipment provider’s stock worth $5,389,765,000 after purchasing an additional 838,793 shares during the last quarter. Wilmington Savings Fund Society FSB grew its position in Intuitive Surgical by 15,322.2% in the 3rd quarter. Wilmington Savings Fund Society FSB now owns 555,661 shares of the medical equipment provider’s stock worth $272,980,000 after purchasing an additional 552,058 shares in the last quarter. Finally, State Street Corp increased its stake in Intuitive Surgical by 1.4% in the 3rd quarter. State Street Corp now owns 15,050,121 shares of the medical equipment provider’s stock valued at $7,393,673,000 after buying an additional 210,363 shares during the last quarter. Institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Stock Down 0.2 %

Shares of ISRG opened at $572.71 on Thursday. Intuitive Surgical, Inc. has a twelve month low of $364.17 and a twelve month high of $616.00. The stock has a market cap of $203.99 billion, a PE ratio of 92.08, a P/E/G ratio of 5.19 and a beta of 1.39. The business’s 50-day moving average price is $548.70 and its 200-day moving average price is $507.04.

Insider Activity

In other Intuitive Surgical news, Director Amal M. Johnson sold 4,635 shares of the company’s stock in a transaction that occurred on Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total value of $2,626,191.00. Following the completion of the sale, the director now owns 12,275 shares of the company’s stock, valued at $6,955,015. This represents a 27.41 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CFO Jamie Samath sold 94 shares of Intuitive Surgical stock in a transaction that occurred on Wednesday, January 29th. The stock was sold at an average price of $571.11, for a total transaction of $53,684.34. Following the transaction, the chief financial officer now directly owns 2,630 shares in the company, valued at $1,502,019.30. This trade represents a 3.45 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 28,843 shares of company stock worth $15,357,560 in the last three months. Corporate insiders own 0.90% of the company’s stock.

Analyst Ratings Changes

Several research firms have recently issued reports on ISRG. Citigroup upped their target price on Intuitive Surgical from $640.00 to $711.00 and gave the company a “buy” rating in a report on Friday, January 24th. The Goldman Sachs Group set a $604.00 price objective on Intuitive Surgical in a research note on Friday, October 18th. JPMorgan Chase & Co. lifted their target price on Intuitive Surgical from $575.00 to $675.00 and gave the stock an “overweight” rating in a research note on Friday, January 24th. Raymond James increased their price target on shares of Intuitive Surgical from $560.00 to $688.00 and gave the company an “outperform” rating in a research report on Friday, January 24th. Finally, Erste Group Bank raised shares of Intuitive Surgical from a “hold” rating to a “buy” rating in a research report on Tuesday, November 19th. One analyst has rated the stock with a sell rating, five have given a hold rating and sixteen have assigned a buy rating to the company. Based on data from MarketBeat.com, Intuitive Surgical presently has an average rating of “Moderate Buy” and an average target price of $613.10.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.